Your browser doesn't support javascript.
loading
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.
Mazieres, J; Cropet, C; Montané, L; Barlesi, F; Souquet, P J; Quantin, X; Dubos-Arvis, C; Otto, J; Favier, L; Avrillon, V; Cadranel, J; Moro-Sibilot, D; Monnet, I; Westeel, V; Le Treut, J; Brain, E; Trédaniel, J; Jaffro, M; Collot, S; Ferretti, G R; Tiffon, C; Mahier-Ait Oukhatar, C; Blay, J Y.
Affiliation
  • Mazieres J; Thoracic Oncology Unit, IFCT (Intergroupe Français de Cancérologie Thoracique), Respiratory Disease Department, Larrey Hospital, CHU Toulouse, Université Paul Sabatier, Toulouse, France. Electronic address: mazieres.j@chu-toulouse.fr.
  • Cropet C; Direction of Clinical Research and Innovation, Biostatistics Department, Centre Léon Bérard, Lyon, France.
  • Montané L; Direction of Clinical Research and Innovation, Biostatistics Department, Centre Léon Bérard, Lyon, France.
  • Barlesi F; Multidisciplinary Oncology & Therapeutic Innovations Department, IFCT, Aix-Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France.
  • Souquet PJ; Thoracic Oncology Department, IFCT, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France.
  • Quantin X; Respiratory Diseases Department, Hôpital Arnaud de Villeneuve, Montpellier, France.
  • Dubos-Arvis C; Pneumology Department, Centre François Baclesse, Caen, France.
  • Otto J; Department of Medicine, Centre Antoine Lacassagne, Nice, France.
  • Favier L; Oncology Department, Centre Georges François Leclerc, Dijon, France.
  • Avrillon V; Centre Léon Bérard & Centre de Recherche en Cancérologie de Lyon & Université Claude Bernard Lyon I, Lyon, France.
  • Cadranel J; Pneumology Department, IFCT, Hôpital Tenon APHP and GRC #4 Theranoscan, Sorbonne Université, Paris, France.
  • Moro-Sibilot D; IFCT, University Pneumology Clinic, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France.
  • Monnet I; Pneumology Department, Centre Hospitalier Intercommunal, Créteil, France.
  • Westeel V; Pneumology Department, IFCT, Hôpital Jean Minjoz, CHU Besançon, Besançon, France.
  • Le Treut J; Respiratory Diseases Department, Centre Hospitalier Intercommunal Aix Pertuis, Aix en Provence, France.
  • Brain E; Department of Medical Oncology, Institut Curie/Saint-Cloud, Saint-Cloud, France.
  • Trédaniel J; Groupe Hospitalier Paris Saint Joseph, Université Paris Descartes, Sorbonne Paris Cité Unité INSERM UMR-S 1124, Paris, France.
  • Jaffro M; Radiology and Medical Imagery Department, Hôpital Rangueil-Larrey, CHU Toulouse, Toulouse, France.
  • Collot S; Radiology and Medical Imagery Department, Hôpital Rangueil-Larrey, CHU Toulouse, Toulouse, France.
  • Ferretti GR; Radiology and Medical Imagery Department, CHU Grenoble Alpes & Université Grenoble Alpes, Grenoble, France.
  • Tiffon C; French National Cancer Institute, Boulogne-Billancourt, France.
  • Mahier-Ait Oukhatar C; Research and Development UNICANCER, Paris, France.
  • Blay JY; Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, LYRICAN (NCa_INSERM_DGOS_12563), Université Claude Bernard Lyon I, Lyon, France.
Ann Oncol ; 31(2): 289-294, 2020 02.
Article in En | MEDLINE | ID: mdl-31959346
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: United kingdom